Adamas Pharma says its new Parkinson’s drug isn’t just a more expensive, long-acting version of generic
August 29, 2017 at 13:07 PM EDT
Adamas’ Gocovri will cost between $10,000 and $30,000 a year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|